We are live on ! Find out more
TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Fund
S&P 500
This Quarter Est. Return
+8.97%
1 Year Est. Return
+18.15%
3 Year Est. Return
+62.51%
5 Year Est. Return
+140.53%
10 Year Est. Return
+502.91%
AUM
$2.76B
AUM Growth
-$24.8M
Cap. Flow
-$295M
Cap. Flow %
-10.7%
Top 10 Hldgs %
47.94%
Holding
172
New
14
Increased
31
Reduced
25
Closed
39

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$27.4M
2
SHPG
Shire pic
SHPG
+$25.4M
3
ILMN icon
Illumina
ILMN
+$22.1M
4
MDVN
MEDIVATION, INC.
MDVN
+$19.9M
5
HCA icon
HCA Healthcare
HCA
+$14.3M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$72.3M
2
ALKS icon
Alkermes
ALKS
+$45.9M
3
AET
Aetna Inc
AET
+$36.3M
4
MDRX
Veradigm Inc. Common Stock
MDRX
+$23M
5
AKRX
Akorn Inc
AKRX
+$22M

Sector Composition

Rank Sector Weight
1 Healthcare 88.47%
2 Real Estate 3.59%
3 Financials 0%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
151
CALL
Viatris
VTRS
$20.7B
– –
-118,000
Closed -$4.75M
EPZM
152
DELISTED
Epizyme, Inc
EPZM
– –
-256,700
Closed -$3.3M
TRIL
153
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-65,000
Closed -$847K
ALXN
154
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-18,200
Closed -$2.85M
GWPH
155
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-41,400
Closed -$3.78M
WMGI
156
DELISTED
Wright Medical Group Inc
WMGI
– –
-156,100
Closed -$3.28M
AGN
157
CALL
DELISTED
Allergan plc
AGN
– –
-35,600
Closed -$9.68M
ACHN
158
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-547,300
Closed -$3.78M
HZNP
159
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-162,900
Closed -$3.23M
AET
160
CALL
DELISTED
Aetna Inc
AET
– –
-84,300
Closed -$9.22M
AET
161
DELISTED
Aetna Inc
AET
– –
-331,931
Closed -$36.3M
AEGR
162
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-206,000
Closed -$2.8M
BDSI
163
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-250,000
Closed -$1.39M
CELG
164
CALL
DELISTED
Celgene Corp
CELG
– –
-93,300
Closed -$10.1M
ABAX
165
DELISTED
Abaxis Inc
ABAX
– –
-22,466
Closed -$988K
ANAC
166
CALL
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
– –
-65,400
Closed -$7.7M
3 4 5 6
7

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
BWM
BerganKDV Wealth Management Bloomington, Minnesota $1,000M AUM 9.95% 1-Year Est. Return

Tekla Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Tekla Capital Management held 172 positions worth $2.76B, down 0.89% from $2.78B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Tekla Capital Management withdrew a net $295M in Q4 2015, closing 39 positions and reducing 25 holdings. Its most notable exit was Aetna Inc, an estimated $36.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 81% a quarter earlier, followed by Real Estate and Financials.

Against the trend, Tekla Capital Management opened a new position in Sanofi worth $13M.

  • Tekla Capital Management's largest Q4 2015 buy was Sanofi: 305,000 shares worth $13M.
  • Tekla Capital Management added most to Allergan plc in Q4 2015, an estimated $27.4M increase.
  • Tekla Capital Management's biggest Q4 2015 reduction was Viatris, cutting an estimated $72.3M.
  • Tekla Capital Management fully exited Aetna Inc in Q4 2015, selling an estimated $36.3M.
  • Tekla Capital Management's ten largest holdings make up 48% of its $2.76B portfolio in Q4 2015.
  • Tekla Capital Management opened 14 new positions and closed 39 in Q4 2015.
  • Tekla Capital Management's portfolio value fell 0.89% quarter-over-quarter to $2.76B.

Based on Tekla Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.